← All trials
NCT03093870
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 4, 2017
- Primary completion
- Nov 12, 2019
- Completion date
- Apr 17, 2020
- First posted
- Mar 28, 2017
- Last posted
- Aug 3, 2021
- Enrollment
- 151
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Aslan PharmaceuticalsLead sponsor
- bioRASI, LLCCollaborator
- CMIC Co, Ltd. JapanCollaborator
- Syneos HealthCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.